MOSAIC IMMUNOENGINEERING, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
MOSAIC IMMUNOENGINEERING, INC. (CPMV) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$3.60 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$3.55K.
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$29.09K.
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$91.14K.
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$94.87K, a 162.45% decline year-over-year.
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$111.40K.
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$41.16K.
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$64.47K.
- MOSAIC IMMUNOENGINEERING, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$5.50K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 0 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 2 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 7 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.60K 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | -$3.55K 10-Q · filed 2026-05-20 | ||||||
| 2025-12-31 | -$111.40K 10-K · filed 2026-04-15 | ||||||
| 2025-09-30 | -$83.26K 10-Q · filed 2025-11-19 | ||||||
| 2025-06-30 | -$61.44K 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | -$29.09K 10-Q · filed 2026-05-20 | ||||||
| 2024-12-31 | -$41.16K 10-K · filed 2026-04-15 | ||||||
| 2024-09-30 | -$150.44K 10-Q · filed 2025-11-19 | ||||||
| 2024-06-30 | -$152.44K 10-Q · filed 2025-08-19 | ||||||
| 2024-03-31 | -$91.14K 10-Q · filed 2025-05-20 | ||||||
| 2023-12-31 | -$64.47K 10-K · filed 2025-04-15 | ||||||
| 2023-09-30 | $32.25K 10-Q · filed 2024-11-19 | ||||||
| 2023-06-30 | $142.32K 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$94.87K 10-Q · filed 2024-05-14 | ||||||
| 2022-12-31 | -$5.50K 10-K · filed 2024-04-15 | ||||||
| 2022-09-30 | $158.00K 10-Q · filed 2023-11-02 | ||||||
| 2022-06-30 | -$20.15K 10-Q · filed 2023-08-03 | ||||||
| 2022-03-31 | $151.91K 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | -$126.60K 10-K · filed 2023-03-02 | ||||||
| 2021-09-30 | $40.38K 10-Q · filed 2022-11-01 | ||||||
| 2021-06-30 | $229.57K 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | -$142.74K 10-Q · filed 2022-05-10 | ||||||
| 2020-12-31 | $352.24K 10-K · filed 2022-01-26 | ||||||
| 2020-11-30 | $412.03K 10-Q · filed 2020-12-29 | ||||||
| 2020-09-30 | $537.29K 10-Q · filed 2021-11-02 | ||||||
| 2020-08-31 | $550.12K 10-Q · filed 2020-10-15 | ||||||
| 2020-06-30 | $500.00 10-Q · filed 2021-08-03 | ||||||
| 2020-05-31 | $500.00 10-K · filed 2022-01-26 | -$236.76K 10-K · filed 2020-08-24 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-05 | ||||||
| 2020-02-29 | -$59.85K 10-Q · filed 2020-04-08 | ||||||
| 2019-11-30 | $154.27K 10-Q · filed 2020-01-14 | ||||||
| 2019-08-31 | -$70.02K 10-Q · filed 2019-10-11 | ||||||
| 2019-05-31 | -$1.33M 10-K · filed 2020-08-24 | ||||||
| 2019-02-28 | -$354.40K 10-Q · filed 2020-04-08 | ||||||
| 2018-11-30 | -$424.66K 10-Q · filed 2020-01-14 | ||||||
| 2018-08-31 | -$260.32K 10-Q · filed 2019-10-11 | ||||||
| 2018-05-31 | $1.32M 10-K · filed 2019-08-29 |